Callitas Health, Inc. is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. The firm researches, develops and business development processes for its other OTC products, CannaMint strips and orphan drug technologies. Callitas Health was founded on March 11, 2003 and is headquartered in Newport, KY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company